These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8756668)

  • 1. Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation.
    Pistoi S; Roland J; Babinet C; Morello D
    Mol Cell Biol; 1996 Sep; 16(9):5107-16. PubMed ID: 8756668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both coding exons of the c-myc gene contribute to its posttranscriptional regulation in the quiescent liver and regenerating liver and after protein synthesis inhibition.
    Lavenu A; Pistoi S; Pournin S; Babinet C; Morello D
    Mol Cell Biol; 1995 Aug; 15(8):4410-9. PubMed ID: 7623834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of sequences in c-myc mRNA that regulate its steady-state levels.
    Yeilding NM; Rehman MT; Lee WM
    Mol Cell Biol; 1996 Jul; 16(7):3511-22. PubMed ID: 8668167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc mRNA is down-regulated during myogenic differentiation by accelerated decay that depends on translation of regulatory coding elements.
    Yeilding NM; Procopio WN; Rehman MT; Lee WM
    J Biol Chem; 1998 Jun; 273(25):15749-57. PubMed ID: 9624173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation.
    Yeilding NM; Lee WM
    Mol Cell Biol; 1997 May; 17(5):2698-707. PubMed ID: 9111340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5' and 3' non-coding sequences of the c-myc gene, required in vitro for its post-transcriptional regulation, are dispensable in vivo.
    Morello D; Lavenu A; Pournin S; Babinet C
    Oncogene; 1993 Jul; 8(7):1921-9. PubMed ID: 8510935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc, c-fos, and c-jun regulation in the regenerating livers of normal and H-2K/c-myc transgenic mice.
    Morello D; Fitzgerald MJ; Babinet C; Fausto N
    Mol Cell Biol; 1990 Jun; 10(6):3185-93. PubMed ID: 2111449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences.
    Jones TR; Cole MD
    Mol Cell Biol; 1987 Dec; 7(12):4513-21. PubMed ID: 3325826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors.
    Wisdom R; Lee W
    Genes Dev; 1991 Feb; 5(2):232-43. PubMed ID: 1995415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation of c-myc mRNA is required for its post-transcriptional regulation during myogenesis.
    Wisdom R; Lee W
    J Biol Chem; 1990 Nov; 265(31):19015-21. PubMed ID: 2229059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different regulation of class I gene expression in the adult mouse and during development.
    Drezen JM; Nouvel P; Babinet C; Morello D
    J Immunol; 1992 Jul; 149(2):429-37. PubMed ID: 1624790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA.
    Laird-Offringa IA; Elfferich P; van der Eb AJ
    Nucleic Acids Res; 1991 May; 19(9):2387-94. PubMed ID: 1645870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of c-myc 3' to 5' mRNA decay activities in an in vitro system.
    Brewer G
    J Biol Chem; 1998 Dec; 273(52):34770-4. PubMed ID: 9857001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-acting determinants of c-myc mRNA stability.
    Cole MD; Mango SE
    Enzyme; 1990; 44(1-4):167-80. PubMed ID: 2133648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
    Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
    Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein.
    Blackwood EM; Lugo TG; Kretzner L; King MW; Street AJ; Witte ON; Eisenman RN
    Mol Biol Cell; 1994 May; 5(5):597-609. PubMed ID: 7919540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site.
    Nanbru C; Lafon I; Audigier S; Gensac MC; Vagner S; Huez G; Prats AC
    J Biol Chem; 1997 Dec; 272(51):32061-6. PubMed ID: 9405401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice.
    Morello D; Lavenu A; Bandeira A; Portnoi D; Gaillard J; Babinet C
    Oncogene Res; 1989; 4(2):111-25. PubMed ID: 2654814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.